EBGI Category: Motility Disorders
-
Cannabidiol: A Potential Therapeutic Option for Idiopathic and Diabetic Gastroparesis
American College of Gastroenterology / EBGI Journal Articles / Motility Disorders / Cannabidiol: A Potential Therapeutic Option for Idiopathic and Diabetic GastroparesisEBGI Associate Editor Dr Philip Okafor and Gastroparesis expert Dr Linday Nguyen provide an evidence-based review of a randomized controlled trial of efficacy and safety of cannabidiol in idiopathic and diabetic gastroparesis by Zheng T, et.
-
Kiwifruit-A Specific Food To Improve Stool Frequency in Patients with Mild Constipation
American College of Gastroenterology / EBGI Journal Articles / Motility Disorders / Kiwifruit-A Specific Food To Improve Stool Frequency in Patients with Mild ConstipationKiwifruit-A Specific Food to Improve Stool Frequency in Patients With Mild Constipation Philip Schoenfeld, MD, MSEd, MSc (Epi) Chief (Emeritus),…
-
AGA-ACG Clinical Practice Guideline on Chronic Idiopathic Constipation Treatments: Parsing Benefits and Risks
American College of Gastroenterology / EBGI Journal Articles / Colon / AGA-ACG Clinical Practice Guideline on Chronic Idiopathic Constipation Treatments: Parsing Benefits and RisksThis evidence-based summary reviews the new clinical practice guideline from the ACG and AGA on the pharmacological management of chronic idiopathic constipation.
-
Vibrating Capsules for Chronic Constipation: The New Non-Pharmacologic Approach
American College of Gastroenterology / EBGI Journal Articles / Motility Disorders / Vibrating Capsules for Chronic Constipation: The New Non-Pharmacologic ApproachVibrating Capsules for Chronic Constipation: The New Non-Pharmacologic Approach Philip Schoenfeld, MD, MSEd, MSc (Epi) Chief (Emeritus), Gastroenterology Section, John…
-
Tenapanor (IBSRELA) for Treatment of IBS-C: Effective over 26 Weeks
American College of Gastroenterology / EBGI Journal Articles / Motility Disorders / Tenapanor (IBSRELA) for Treatment of IBS-C: Effective over 26 WeeksTenapanor (IBSRELA) for Treatment of IBS-C: Effective Over 26 Weeks Philip Schoenfeld, MD, MSEd, MSc (Epi) Chief (Emeritus)-Gastroenterology Section, John…
-
Treating All the Symptoms of IBS-C
American College of Gastroenterology / EBGI Journal Articles / Motility Disorders / Treating All the Symptoms of IBS-CTreating All the Symptoms of IBS-C: Linaclotide Significantly Decreases Abdominal Pain, Bloating, and Discomfort Jill Deutsch, MD1 and Philip Schoenfeld,…